Phase II study with prolonged infusion gemcitabine in pretreated advanced soft tissue sarcomas of the adult

被引：1
|
作者：
Späth-Schwalbe, E
Genvresse, I
Koschuth, A
Grunewald, R
Possinger, K
机构：
[1] Charite Univ Hosp, Berlin, Germany
[2] Humboldt Univ, Berlin, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81503-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1083
引用
收藏
页码：S271 / S271
页数：1
相关论文
共 50 条
  • [41] Gemcitabine in the treatment of soft tissue sarcomas
    Bauer, S
    Seeber, S
    Schütte, J
    ONKOLOGIE, 2004, 27 (02): : 180 - 186
  • [42] Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Vici, Patrizia
    Fabi, Alessandra
    Metro, Giulio
    Sergi, Domenico
    Giannarelli, Diana
    Di Lauro, Luigi
    Bepler, Gerold
    Tomao, Federica
    Cognetti, Francesco
    Conti, Francesca
    Lopez, Massimo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 687 - 693
  • [43] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS IN THE ADULT - A PHASE II STUDY OF THE EORTC SOFT-TISSUE AND BONE-SARCOMA-GROUP
    BUESA, JM
    MOURIDSEN, HT
    VANOOSTEROM, AT
    VERWEIJ, J
    WAGENER, T
    STEWARD, W
    POVEDA, A
    VESTLEV, PM
    THOMAS, D
    SYLVESTER, R
    ANNALS OF ONCOLOGY, 1991, 2 (04) : 307 - 309
  • [44] Phase Ib study of Decitabine in combination with Gemcitabine in treatment of refractory pancreatic adenocarcinoma and advanced soft tissue or bone sarcomas
    Abushahin, Laith
    Monga, Varum
    Berg, Daniel
    Chandrasekharan, Chandrikha
    Tanas, Munir
    Henry, Michael
    Mckay, Mariel
    Mott, Sarah
    Milhem, Mohammed
    CANCER RESEARCH, 2018, 78 (13)
  • [45] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Juan Martin-Liberal
    Antonio López-Pousa
    Javier Martínez-Trufero
    Javier Martín-Broto
    Ricardo Cubedo
    Javier Lavernia
    Andrés Redondo
    José Antonio López-Martín
    Nùria Mulet-Margalef
    Xavier Sanjuan
    Òscar M. Tirado
    Xavier Garcia-del-Muro
    Targeted Oncology, 2018, 13 : 81 - 87
  • [46] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Martin-Liberal, Juan
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Antonio Lopez-Martin, Jose
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    Garcia-del-Muro, Xavier
    TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
  • [47] Phase II study with Docetaxel (Taxotere) as second line treatment of advanced soft tissues sarcomas in adult
    Verusio, C
    Romanini, A
    Frustaci, S
    Comandone, A
    DeToma, D
    Dogliotti, L
    Piolini, M
    Lionetto, R
    Dani, C
    Santoro, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 507 - 507
  • [48] A phase II trial of low dose prolonged infusion gemcitabine and cisplatin in advanced bladder cancer
    Khaled, Hussein M.
    El-Khodary, Ahmed I.
    Emara, Mohamed E.
    Gaafar, Rabab M.
    Mansour, Osman
    Warith, Amed Abdei
    Zaghloul, Mohamed S.
    El Malt, Osama
    ANNALS OF ONCOLOGY, 2004, 15 : 118 - 118
  • [49] Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group phase II study
    Saeter, G
    Alvegard, TA
    Monge, OR
    Strander, H
    Turesson, I
    Klepp, R
    Soderberg, M
    Wist, E
    Raabe, N
    Erlanson, M
    Solheim, OP
    Hannisdal, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1551 - 1558
  • [50] Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas
    Heymach, JV
    Desai, J
    Manola, J
    Davis, DW
    McConkey, DJ
    Harmon, D
    Ryan, DP
    Goss, G
    Quigley, T
    Van den Abbeele, AD
    Silverman, SG
    Connors, S
    Folkman, J
    Fletcher, CDM
    Demetri, GD
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5732 - 5740
12345